484 related articles for article (PubMed ID: 15730850)
1. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
[TBL] [Abstract][Full Text] [Related]
2. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
3. Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand.
Han JH; Choi SJ; Kurihara N; Koide M; Oba Y; Roodman GD
Blood; 2001 Jun; 97(11):3349-53. PubMed ID: 11369623
[TBL] [Abstract][Full Text] [Related]
4. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
[TBL] [Abstract][Full Text] [Related]
5. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts.
Lean JM; Murphy C; Fuller K; Chambers TJ
J Cell Biochem; 2002; 87(4):386-93. PubMed ID: 12397598
[TBL] [Abstract][Full Text] [Related]
6. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
7. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
8. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.
de Wynter EA; Durig J; Cross MA; Heyworth CM; Testa NG
Stem Cells; 1998; 16(5):349-56. PubMed ID: 9766815
[TBL] [Abstract][Full Text] [Related]
9. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
Kaufmann A; Salentin R; Gemsa D; Sprenger H
J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
[TBL] [Abstract][Full Text] [Related]
10. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
[TBL] [Abstract][Full Text] [Related]
11. Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes.
Møller AS; Øvstebø R; Westvik AB; Joø GB; Haug KB; Kierulf P
J Endotoxin Res; 2003; 9(6):349-60. PubMed ID: 14733721
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1.
Nardelli B; Tiffany HL; Bong GW; Yourey PA; Morahan DK; Li Y; Murphy PM; Alderson RF
J Immunol; 1999 Jan; 162(1):435-44. PubMed ID: 9886417
[TBL] [Abstract][Full Text] [Related]
13. MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.
Liesveld JL; Harbol AW; Belanger T; Rosell KE; Abboud CN
Blood Cells Mol Dis; 2000 Aug; 26(4):261-75. PubMed ID: 11042027
[TBL] [Abstract][Full Text] [Related]
14. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
[TBL] [Abstract][Full Text] [Related]
15. Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages.
Di Marzio P; Dai WW; Franchin G; Chan AY; Symons M; Sherry B
Biochem Biophys Res Commun; 2005 Jun; 331(4):909-16. PubMed ID: 15882964
[TBL] [Abstract][Full Text] [Related]
16. MIP-1 alpha and myeloma bone disease.
Roodman GD; Choi SJ
Cancer Treat Res; 2004; 118():83-100. PubMed ID: 15043189
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
[TBL] [Abstract][Full Text] [Related]
18. Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma.
Oyajobi BO; Mundy GR
Cancer; 2003 Feb; 97(3 Suppl):813-7. PubMed ID: 12548580
[TBL] [Abstract][Full Text] [Related]
19. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J
Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-inflammatory protein-1alpha receptor expression on normal and chronic myeloid leukemia CD34+ cells.
Nicholls SE; Lucas G; Graham GJ; Russell NH; Mottram R; Whetton AD; Buckle AM
J Immunol; 1999 May; 162(10):6191-9. PubMed ID: 10229864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
